During the past decade, University of Rochester Cancer Center conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 17 clinical trials were completed, i.e. on average, 44.7% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 8 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Rochester Cancer Center" #1 sponsor was "Radiation Therapy Oncology Group" with 35 trials, followed by "University of Rochester" with 25 trials sponsored, "Eastern Cooperative Oncology Group" with 24 trials sponsored, "Gynecologic Oncology Group" with 21 trials sponsored and "Children's Oncology Group" with 21 trials sponsored. Other sponsors include 70 different institutions and companies that sponsored additional 56 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Rochester Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 119 trials as a collaborator, "Eastern Cooperative Oncology Group" with 8 trials as a collaborator, "North Central Cancer Treatment Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "NRG Oncology" with 3 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "University of Rochester Cancer Center" are "Head and Neck Cancer" (14 trials), "Ovarian Cancer" (14 trials), "Leukemia" (13 trials), "Lymphoma" (12 trials) and "Prostate Cancer" (11 trials). Many other conditions were trialed in "University of Rochester Cancer Center" in a lesser frequency.

Most popular intervention types in "University of Rochester Cancer Center" are "Drug" (153 trials), "Radiation" (50 trials), "Biological" (46 trials), "Procedure" (44 trials) and "Other" (10 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (41 trials), "paclitaxel" (25 trials), "cisplatin" (23 trials), "filgrastim" (19 trials) and "conventional surgery" (16 trials). Other intervention names were less common.

The vast majority of trials in "University of Rochester Cancer Center" are 154 trials for "All" genders, 32 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are 27 active trials in "University of Rochester Cancer Center". 1 are not yet recruiting, 16 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 157 completed trials in University of Rochester Cancer Center, 1 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in University of Rochester Cancer Center, 36 "Phase 1" clinical trials were conducted, 107 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".